---
title: "NG CAREY — Ownership Dossier"
canonical: https://whiteintel.dev/entity/42e734e5-359f-5d25-b524-a6712d3cd162
json: https://whiteintel.dev/api/public/dossier/42e734e5-359f-5d25-b524-a6712d3cd162
identifier: sec:0001889522
jurisdiction: US
risk: Low
source: WhiteIntel corporate-ownership graph
---

# NG CAREY

**Type:** Company  
**Jurisdiction:** [US](https://whiteintel.dev/jurisdictions/us)  
**Identifier:** `sec:0001889522`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/42e734e5-359f-5d25-b524-a6712d3cd162  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/42e734e5-359f-5d25-b524-a6712d3cd162  

## Ownership & control

### Holdings / subsidiaries

- **IMMIX BIOPHARMA, INC.** (director) — https://whiteintel.dev/entity/b218e786-d21a-574b-aa93-90bd2fc008c7

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **NG CAREY**. Human view: https://whiteintel.dev/entity/42e734e5-359f-5d25-b524-a6712d3cd162 · Structured JSON: https://whiteintel.dev/api/public/dossier/42e734e5-359f-5d25-b524-a6712d3cd162._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._